RS61657B1 - Derivati 3-metil-pirolidin-2,5-diona korisni kao antagonisti cgrp receptora - Google Patents
Derivati 3-metil-pirolidin-2,5-diona korisni kao antagonisti cgrp receptoraInfo
- Publication number
- RS61657B1 RS61657B1 RS20210400A RSP20210400A RS61657B1 RS 61657 B1 RS61657 B1 RS 61657B1 RS 20210400 A RS20210400 A RS 20210400A RS P20210400 A RSP20210400 A RS P20210400A RS 61657 B1 RS61657 B1 RS 61657B1
- Authority
- RS
- Serbia
- Prior art keywords
- pyrrolidine
- methyl
- receptor antagonists
- derivatives useful
- cgrp receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762506204P | 2017-05-15 | 2017-05-15 | |
| PCT/US2018/031526 WO2018213059A1 (en) | 2017-05-15 | 2018-05-08 | 3-methyl-pyrrolidine-2,5-dione derivatives useful as cgrp receptor antagonists |
| EP18727529.2A EP3625221B1 (en) | 2017-05-15 | 2018-05-08 | 3-methyl-pyrrolidine-2,5-dione derivatives useful as cgrp receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS61657B1 true RS61657B1 (sr) | 2021-04-29 |
Family
ID=62245454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20210400A RS61657B1 (sr) | 2017-05-15 | 2018-05-08 | Derivati 3-metil-pirolidin-2,5-diona korisni kao antagonisti cgrp receptora |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10336726B2 (sr) |
| EP (1) | EP3625221B1 (sr) |
| JP (1) | JP6794583B2 (sr) |
| CN (1) | CN110662741B (sr) |
| AR (1) | AR111665A1 (sr) |
| CA (1) | CA3061762C (sr) |
| CY (1) | CY1124032T1 (sr) |
| DK (1) | DK3625221T3 (sr) |
| ES (1) | ES2870325T3 (sr) |
| HR (1) | HRP20210655T1 (sr) |
| HU (1) | HUE054448T2 (sr) |
| LT (1) | LT3625221T (sr) |
| PL (1) | PL3625221T3 (sr) |
| PT (1) | PT3625221T (sr) |
| RS (1) | RS61657B1 (sr) |
| SI (1) | SI3625221T1 (sr) |
| TW (1) | TW201904955A (sr) |
| WO (1) | WO2018213059A1 (sr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11066386B2 (en) | 2017-05-15 | 2021-07-20 | Eli Lilly And Company | CGRP receptor antagonists |
| CN114746409A (zh) * | 2019-12-12 | 2022-07-12 | 伊莱利利公司 | 可用作正电子发射断层扫描术的示踪剂化合物的cgrp拮抗剂 |
| CN115704811B (zh) * | 2022-12-26 | 2023-03-31 | 南京威凯尔生物医药科技有限公司 | 一种高效液相色谱法检测乌布吉泮及其对映体和非对映体杂质的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6680387B2 (en) | 2000-04-24 | 2004-01-20 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| EP2846798B1 (en) | 2012-05-09 | 2018-04-04 | Merck Sharp & Dohme Corp. | Aliphatic spirolactam cgrp receptor antagonists |
| TW201718574A (zh) | 2015-08-12 | 2017-06-01 | 美國禮來大藥廠 | Ｃｇｒｐ受體拮抗劑 |
| TWI636041B (zh) * | 2015-08-12 | 2018-09-21 | 美國禮來大藥廠 | Ｃｇｒｐ受體拮抗劑 |
-
2018
- 2018-05-02 TW TW107114809A patent/TW201904955A/zh unknown
- 2018-05-02 AR ARP180101138A patent/AR111665A1/es unknown
- 2018-05-08 CA CA3061762A patent/CA3061762C/en active Active
- 2018-05-08 LT LTEP18727529.2T patent/LT3625221T/lt unknown
- 2018-05-08 CN CN201880032549.5A patent/CN110662741B/zh not_active Expired - Fee Related
- 2018-05-08 PL PL18727529T patent/PL3625221T3/pl unknown
- 2018-05-08 ES ES18727529T patent/ES2870325T3/es active Active
- 2018-05-08 EP EP18727529.2A patent/EP3625221B1/en active Active
- 2018-05-08 HU HUE18727529A patent/HUE054448T2/hu unknown
- 2018-05-08 RS RS20210400A patent/RS61657B1/sr unknown
- 2018-05-08 WO PCT/US2018/031526 patent/WO2018213059A1/en unknown
- 2018-05-08 PT PT187275292T patent/PT3625221T/pt unknown
- 2018-05-08 US US15/973,681 patent/US10336726B2/en not_active Expired - Fee Related
- 2018-05-08 DK DK18727529.2T patent/DK3625221T3/da active
- 2018-05-08 SI SI201830241T patent/SI3625221T1/sl unknown
- 2018-05-08 JP JP2020512768A patent/JP6794583B2/ja active Active
-
2021
- 2021-04-06 CY CY20211100293T patent/CY1124032T1/el unknown
- 2021-04-26 HR HRP20210655TT patent/HRP20210655T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN110662741B (zh) | 2022-08-16 |
| PL3625221T3 (pl) | 2021-08-23 |
| AR111665A1 (es) | 2019-08-07 |
| EP3625221A1 (en) | 2020-03-25 |
| JP2020519686A (ja) | 2020-07-02 |
| CN110662741A (zh) | 2020-01-07 |
| CA3061762A1 (en) | 2018-11-22 |
| DK3625221T3 (da) | 2021-04-19 |
| WO2018213059A1 (en) | 2018-11-22 |
| CY1124032T1 (el) | 2022-05-27 |
| HRP20210655T1 (hr) | 2021-05-28 |
| LT3625221T (lt) | 2021-04-26 |
| JP6794583B2 (ja) | 2020-12-02 |
| US10336726B2 (en) | 2019-07-02 |
| EP3625221B1 (en) | 2021-03-03 |
| ES2870325T3 (es) | 2021-10-26 |
| SI3625221T1 (sl) | 2021-04-30 |
| US20180327384A1 (en) | 2018-11-15 |
| CA3061762C (en) | 2021-11-09 |
| TW201904955A (zh) | 2019-02-01 |
| HUE054448T2 (hu) | 2021-09-28 |
| PT3625221T (pt) | 2021-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272056A (en) | Heterocyclic compounds as adenosine antagonists | |
| IL266472A (en) | Indazole derivatives as alpha-v-integrin antagonists | |
| IL260307A (en) | Substituted thiohydantoin derivatives as androgen receptor antagonists | |
| SG11202001340VA (en) | Quinoxaline derivatives as adenosine receptor antagonists | |
| IL258892B (en) | Calcitonin gene-related peptide receptor antagonists | |
| HK1249095A1 (zh) | Cgrp受體拮抗劑 | |
| IL258894A (en) | Cgrp receptor antagonists | |
| LT3625221T (lt) | 3-metilpirolidin-2,5-diono dariniai, naudotini kaip cgrp receptoriaus antagonistai | |
| SG11202104081XA (en) | 5-azaindazole derivatives as adenosine receptor antagonists | |
| SG11202001337XA (en) | Bezimidazole derivatives as adenosine receptor antagonists | |
| IL258893A (en) | Cgrp receptor antagonists | |
| SG11202104078PA (en) | 5-azaindazole derivatives as adenosine receptor antagonists | |
| ZA202000758B (en) | Fluoropiperidine compounds as pure 5-ht6 receptor antagonists | |
| HK1257896B (zh) | 作為trpm8拮抗劑的(4-羥基-2-苯基-1，3-噻唑-5-基)甲酮衍生物 | |
| GB201805675D0 (en) | Compounds For Use As Apelin Receptor Antagonists |